131 related articles for article (PubMed ID: 38127826)
21. Prevalence of Germline Alterations on Targeted Tumor-Normal Sequencing of Esophagogastric Cancer.
Ku GY; Kemel Y; Maron SB; Chou JF; Ravichandran V; Shameer Z; Maio A; Won ES; Kelsen DP; Ilson DH; Capanu M; Strong VE; Molena D; Sihag S; Jones DR; Coit DG; Tuvy Y; Cowie K; Solit DB; Schultz N; Hechtman JF; Offit K; Joseph V; Mandelker D; Janjigian YY; Stadler ZK
JAMA Netw Open; 2021 Jul; 4(7):e2114753. PubMed ID: 34251444
[TBL] [Abstract][Full Text] [Related]
22. Biallelic inactivation of the SDHC gene in renal carcinoma associated with paraganglioma syndrome type 3.
Malinoc A; Sullivan M; Wiech T; Schmid KW; Jilg C; Straeter J; Deger S; Hoffmann MM; Bosse A; Rasp G; Eng C; Neumann HP
Endocr Relat Cancer; 2012 Jun; 19(3):283-90. PubMed ID: 22351710
[TBL] [Abstract][Full Text] [Related]
23. Cancer Susceptibility Mutations in Patients With Urothelial Malignancies.
Carlo MI; Ravichandran V; Srinavasan P; Bandlamudi C; Kemel Y; Ceyhan-Birsoy O; Mukherjee S; Mandelker D; Chaim J; Knezevic A; Rana S; Fnu Z; Breen K; Arnold AG; Khurram A; Tkachuk K; Cipolla CK; Regazzi A; Hakimi AA; Al-Ahmadie H; Dalbagni G; Cadoo KA; Walsh MF; Teo MY; Funt SA; Coleman JA; Bochner BH; Iyer G; Solit DB; Stadler ZK; Zhang L; Rosenberg JE; Taylor BS; Robson ME; Berger MF; Vijai J; Bajorin DF; Offit K
J Clin Oncol; 2020 Feb; 38(5):406-414. PubMed ID: 31794323
[TBL] [Abstract][Full Text] [Related]
24. Germline mutations of renal cancer predisposition genes and clinical relevance in Chinese patients with sporadic, early-onset disease.
Wu J; Wang H; Ricketts CJ; Yang Y; Merino MJ; Zhang H; Shi G; Gan H; Linehan WM; Zhu Y; Ye D
Cancer; 2019 Apr; 125(7):1060-1069. PubMed ID: 30548481
[TBL] [Abstract][Full Text] [Related]
25. Familial non-VHL clear cell (conventional) renal cell carcinoma: clinical features, segregation analysis, and mutation analysis of FLCN.
Woodward ER; Ricketts C; Killick P; Gad S; Morris MR; Kavalier F; Hodgson SV; Giraud S; Bressac-de Paillerets B; Chapman C; Escudier B; Latif F; Richard S; Maher ER
Clin Cancer Res; 2008 Sep; 14(18):5925-30. PubMed ID: 18794106
[TBL] [Abstract][Full Text] [Related]
26. Detection of germline variants in Brazilian breast cancer patients using multigene panel testing.
Guindalini RSC; Viana DV; Kitajima JPFW; Rocha VM; López RVM; Zheng Y; Freitas É; Monteiro FPM; Valim A; Schlesinger D; Kok F; Olopade OI; Folgueira MAAK
Sci Rep; 2022 Mar; 12(1):4190. PubMed ID: 35264596
[TBL] [Abstract][Full Text] [Related]
27. Pathogenicity of VHL variants in families with non-syndromic von Hippel-Lindau phenotypes: An integrated evaluation of germline and somatic genomic results.
Rana HQ; Koeller DR; Schwartz A; Manning DK; Schneider KA; Krajewski KM; Choueiri TK; Lindeman NI; Garber JE; Ghazani AA
Eur J Med Genet; 2021 Dec; 64(12):104359. PubMed ID: 34628056
[TBL] [Abstract][Full Text] [Related]
28. Ethnic disparities among men with prostate cancer undergoing germline testing.
Kwon DH; Borno HT; Cheng HH; Zhou AY; Small EJ
Urol Oncol; 2020 Mar; 38(3):80.e1-80.e7. PubMed ID: 31630993
[TBL] [Abstract][Full Text] [Related]
29. Clear cell and papillary renal cell carcinomas in hereditary papillary renal cell carcinoma (HPRCC) syndrome: a case report.
Ferlicot S; Just PA; Compérat E; Rouleau E; Tissier F; Vaessen C; Richard S
Diagn Pathol; 2021 Nov; 16(1):107. PubMed ID: 34801057
[TBL] [Abstract][Full Text] [Related]
30. Two unique BAP1 pathogenic variants identified in the same family by panel cascade testing.
Byrne L; Ingalls C; Ansari A; Porteus C; Donenberg TR; Sussman DA; Cebulla CM; Abdel-Rahman MH
Fam Cancer; 2023 Jul; 22(3):307-311. PubMed ID: 36513904
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of BRCA1 and BRCA2 pathogenic and likely pathogenic variants in non-selected ovarian carcinoma patients in Brazil.
Cotrim DP; Ribeiro ARG; Paixão D; de Queiroz Soares DC; Jbili R; Pandolfi NC; Cezana C; de Cássia Mauro C; Mantoan H; Bovolim G; de Brot L; Torrezan GT; Carraro DM; Baiocchi G; da Cruz Formiga MN; da Costa AABA
BMC Cancer; 2019 Jan; 19(1):4. PubMed ID: 30606148
[TBL] [Abstract][Full Text] [Related]
32. Germline Testing identifies Pathogenic/Likely Pathogenic Variants in Patients with Pancreatic Neuroendocrine Tumors.
Mohindroo C; Baydogan S; Agarwal P; Wright RD; Prakash LR; Mork ME; Klein AP; Laheru DA; Maxwell JE; Katz MHG; Dasari A; Kim MP; He J; McAllister F; De Jesus-Acosta A
Cancer Prev Res (Phila); 2024 Apr; ():. PubMed ID: 38662083
[TBL] [Abstract][Full Text] [Related]
33. Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement.
Bratslavsky G; Mendhiratta N; Daneshvar M; Brugarolas J; Ball MW; Metwalli A; Nathanson KL; Pierorazio PM; Boris RS; Singer EA; Carlo MI; Daly MB; Henske EP; Hyatt C; Middleton L; Morris G; Jeong A; Narayan V; Rathmell WK; Vaishampayan U; Lee BH; Battle D; Hall MJ; Hafez K; Jewett MAS; Karamboulas C; Pal SK; Hakimi AA; Kutikov A; Iliopoulos O; Linehan WM; Jonasch E; Srinivasan R; Shuch B
Cancer; 2021 Nov; 127(21):3957-3966. PubMed ID: 34343338
[TBL] [Abstract][Full Text] [Related]
34. [Heredity in renal and prostatic neoplasia].
Prayer Galetti T; D'Arrigo L; De Zorzi L; Patarnello T
Arch Ital Urol Androl; 1997 Sep; 69(4):241-6. PubMed ID: 9417296
[TBL] [Abstract][Full Text] [Related]
35. Whole Exome Sequencing Identifies Candidate Genes Associated with Hereditary Predisposition to Uveal Melanoma.
Abdel-Rahman MH; Sample KM; Pilarski R; Walsh T; Grosel T; Kinnamon D; Boru G; Massengill JB; Schoenfield L; Kelly B; Gordon D; Johansson P; DeBenedictis MJ; Singh A; Casadei S; Davidorf FH; White P; Stacey AW; Scarth J; Fewings E; Tischkowitz M; King MC; Hayward NK; Cebulla CM
Ophthalmology; 2020 May; 127(5):668-678. PubMed ID: 32081490
[TBL] [Abstract][Full Text] [Related]
36. Associations Between Cancer Predisposition Mutations and Clonal Hematopoiesis in Patients With Solid Tumors.
Franch-Expósito S; Mehine M; Ptashkin RN; Bolton KL; Bandlamudi C; Srinivasan P; Zhang L; Goodell MA; Gedvilaite E; Menghrajani K; Sánchez-Vela P; Mandelker D; Comen E; Norton L; Benayed R; Gao T; Papaemmanuil E; Taylor B; Levine R; Offit K; Stadler Z; Berger MF; Zehir A
JCO Precis Oncol; 2023 Aug; 7():e2300070. PubMed ID: 37561983
[TBL] [Abstract][Full Text] [Related]
37. Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management.
Shuch B; Vourganti S; Ricketts CJ; Middleton L; Peterson J; Merino MJ; Metwalli AR; Srinivasan R; Linehan WM
J Clin Oncol; 2014 Feb; 32(5):431-7. PubMed ID: 24378414
[TBL] [Abstract][Full Text] [Related]
38. Clues to recognition of fumarate hydratase-deficient renal cell carcinoma: Findings from cytologic and limited biopsy samples.
Shyu I; Mirsadraei L; Wang X; Robila V; Mehra R; McHugh JB; Chen YB; Udager AM; Gill AJ; Cheng L; Amin MB; Lin O; Smith SC
Cancer Cytopathol; 2018 Dec; 126(12):992-1002. PubMed ID: 30339328
[TBL] [Abstract][Full Text] [Related]
39. Candidate variants in DNA replication and repair genes in early-onset renal cell carcinoma patients referred for germline testing.
Demidova EV; Serebriiskii IG; Vlasenkova R; Kelow S; Andrake MD; Hartman TR; Kent T; Virtucio J; Rosen GL; Pomerantz RT; Dunbrack RL; Golemis EA; Hall MJ; Chen DYT; Daly MB; Arora S
BMC Genomics; 2023 Apr; 24(1):212. PubMed ID: 37095444
[TBL] [Abstract][Full Text] [Related]
40. Germline mutations in homologous recombination repair genes among Chinese pancreatic ductal adenocarcinoma patients detected using next-generation sequencing.
Jiang H; Huang F; Chen X; Zhang L; Shen M; Pan B; Wang B; Guo W
Mol Genet Genomic Med; 2023 Jul; 11(7):e2170. PubMed ID: 36978154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]